About Careers MedBlog Contact us

Scientists Reprogram Tumor-Promoting Cancer Cells to Their Original Cell Type

by Bidita Debnath on April 22, 2015 at 12:11 AM
Font : A-A+

Scientists Reprogram Tumor-Promoting Cancer Cells to Their Original Cell Type

Researchers have found a new way to restore pancreatic cancer cells to their original state by introducing a protein, thereby offering a potential novel therapeutic approach to combat this highly lethal disease.

"For the first time, we have shown that over-expression of a single gene can reduce the tumor-promoting potential of pancreatic adenocarcinoma cells and reprogram them toward their original cell type," said Pamela Itkin-Ansari, adjunct professor at Sanford-Burnham Medical Research Institute in the US. "Thus, pancreatic cancer cells retain a genetic memory which we hope to exploit," Itkin-Ansari said.


The study generated human pancreatic ductal adenocarcinoma cell lines to make higher than normal levels of the protein E47. The increased amount of E47 caused the pancreatic cancer cells to revert back towards normal cells.

When the reprogrammed cancer cells were introduced into mice, their ability to form tumors was greatly diminished compared to untreated adenocarcinoma cells.

"Presently, pancreatic adenocarcinoma is treated with cytotoxic agents, yet the average survival for patients post-diagnosis is merely six months, and the improvements in therapies are measured in days," Andrew Lowy, professor of surgery at the University of California San Diego Moores Cancer Center said. "The finding that we can differentiate these cancer cells back to a non-threatening phenotype is encouraging," Lowy said.

The study appeared in the journal Pancreas.

Source: IANS


Recommended Reading

Latest Cancer News

Could TKI Cancer Drugs Lead to Inflammatory Side Effects?
The mechanism by which the kinases cause inflammation has been discovered by scientists.
Are Biomarkers the Key to Identifying Early Pancreatic Risk?
Pancreatic cancer cases are on the rise. The biomarker approach could reduce the chance of developing pancreatic cancer.
How Does New Drugs Work Together to Reduce Lung Tumors?
New combination of medications trametinib and entinostat were found to decrease lung cancer in mice.
New Combination Therapy Proves Effective Against Prostate Cancer
Combination treatment with TALZENNA and XTANDI was found to benefit prostate cancer patients, revealed study.
Can Vitamin A Rich Diet Help Reduce Pancreatitis Risk
In leukemia patients, reduced amounts of dietary vitamin A is associated with a higher risk and severity of pancreatitis.
View All
open close


Scientists Reprogram Tumor-Promoting Cancer Cells to Their Original Cell Type Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests